Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals has announced the closure of its trading window starting 1st January 2026, in line with SEBI's Insider Trading Regulations. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ending 31st December 2025. All designated persons and their immediate relatives are barred from trading in the company's shares during this blackout period. The date of the board meeting to approve the Q3 FY26 results will be communicated separately.
This is a routine compliance announcement ahead of quarterly results and does not directly affect the stock price. It signals that Q3 FY26 earnings are expected soon, which investors should watch for as the next key catalyst.